Showing results (101-110 of 366) with videos related to
Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer SusceptibilityMark E Robson, Angela R Bradbury, Banu Arun, et al.British Journal of Cancer|December 3, 2019
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutationMax M Wattenberg, Daniella Asch, Shun Yu, et al.JCO Precision Oncology|February 1, 2022
Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 MutationShun Yu, Parul Agarwal, Ronac Mamtani, et al.Journal of Voice : Official Journal of the Voice Foundation|July 11, 2023
Prevalence of Laryngeal Muscle Tension in Patients With Obstructive Sleep ApneaAbdul-Latif Hamdan, Anthony Ghanem, Jad Hosri, et al.Journal of Voice : Official Journal of the Voice Foundation|March 16, 2023
The Added Value of Steroid Injection Following Office-based Blue Laser Therapy of Benign Lesions of the Vocal Folds; Short-Term Effect in a Cohort of 43 PatientsAbdul-Latif Hamdan, Anthony Ghanem, Christophe Abi Zeid Daou, et al.Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|October 8, 2024
The Risk of Obstructive Sleep Apnea in Patients with Primary Muscle Tension DysphoniaAbdul-Latif Hamdan, Christophe Abi Zeid Daou, Jad Hosri, et al.Journal of Fungi (Basel, Switzerland)|August 25, 2023
Mucormycosis: A 14-Year Retrospective Study from a Tertiary Care Center in LebanonFatima Allaw, Johnny Zakhour, Sarah B Nahhal, et al.Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.Gynecologic Oncology|July 27, 2021
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomyMartha Hickey, Katrina M Moss, Efrosinia O Krejany, et al.JCO Precision Oncology|February 24, 2022
PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian CancerAdam A Kraya, Kara N Maxwell, Monika A Eiva, et al.Pageof 37